Featured Story

CMOs on Fire

Four contract manufacturers who are redefining what it means to outsource

PM1901 WebLeadImage 295X269

Recently, contract manufacturers have taken the conventional definition of outsourcing, and set it on fire. Traditionally, CMOs provided capacity reservoirs for pharma companies to tap as needed. For decades, outsourcing to contract manufacturers has been a valuable — even vital — option, allowing pharma companies to focus their resources on their primary objectives.But the days of CMOs being faceless, behind-the-scenes workhorses are long gone. Now, as major pharmaceutical companies lumber through transformations slowly, up-and-coming CMOs are often zipping ahead of the pack and offering savvy and efficient solutions to making the best-quality products.Smart…

Full Story

Don't Miss These Pharma Manufacturing Exclusives

Fundamentals

On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Sustainable From the Start

    By Karen Langhauser, Chief Content Director

    China is the world’s largest producer and exporter of active pharmaceutical ingredients (APIs) and a major supplier to the U.S. But recent history has seen several Chinese API producers thrust into the media hot seat for various offenses, including quality issues, improper waste management and…

    Full Story
  • CMOs on Fire

    Recently, contract manufacturers have taken the conventional definition of outsourcing, and set it on fire. Traditionally, CMOs provided capacity reservoirs for pharma companies to tap as needed. For decades, outsourcing to contract manufacturers has been a valuable — even vital — option,…

    Full Story
  • At the Forefront of ADC Manufacturing

    By Meagan Parrish, Senior Editor

    The predictions vary for exactly how much the market for antibody drug conjugates (ADCs) will take off in the coming years, but one factor is the same for analysts — growth will be in the billions.The allure of ADCs — especially in oncology — is apparent. Because the technology combines a…

    Full Story
  • Build Biologics Not Barriers

    By Karen Langhauser, Chief Content Director

    The current trade conflict between the world's biggest economies — the United States and China — has resulted in both countries imposing billions of dollars’ worth of tariffs on each other’s goods. At the time of writing, U.S. and Chinese officials are meeting in Beijing, attempting to…

    Full Story
  • Rethinking Isolation

    By Meagan Parrish, Senior Editor

    BSM put together existing technology to create a novel isolator system can fill vials, syringes and cartridges in a variety of sizes. When Shawn Kinney and his team launched Berkshire Sterile Manufacturing (BSM) in 2014, the aim was to tap into a sector of the industry they felt was underserved…

    Full Story
  • External Partnerships, Redefined

    By Leila Schwery-Bou-Diab, Vice President, Partnerships and External Supply, The Pharmaceutical Companies of Johnson & Johnson (Janssen)

    The pharmaceutical supply chain is the sum of the all steps required for the production and distribution of medicines.The Janssen Supply Chain comprises 21 sites globally and, in addition, entrusts supply contracts to more than 100 external partners. A complex challenge like this cannot succeed…

    Full Story

Latest Products